Mylan Pharmaceuticals
Mylan Pharmaceuticals, now part of Viatris, is a global leader in providing high-quality generic and specialty medications. Founded in 1961, Mylan began as a small distributor of antibiotics in West Virginia, USA, and grew into one of the world's largest producers of generic medicines, known for its commitment to access, quality, and innovation.
Overview of Mylan Pharmaceuticals
- Founded: 1961 in White Sulphur Springs, West Virginia.
- Headquarters: Originally in the United States; now part of Viatris, headquartered in Canonsburg, Pennsylvania.
- Global Reach: Operates in over 165 countries and territories, supplying medicines to millions.
Core Strengths
Expansive Portfolio
- Mylan offers a wide range of medications, including:
- Generic Medicines: Affordable alternatives to brand-name drugs across multiple therapeutic categories, including oncology, cardiology, and infectious diseases.
- Specialty Drugs: Unique formulations addressing conditions like HIV/AIDS, respiratory illnesses, and neurological disorders.
- Over-the-Counter Products: Consumer health solutions like vitamins and dietary supplements.
Commitment to Access
Mylan focuses on reducing barriers to medication access by manufacturing affordable treatments without compromising quality. It is particularly renowned for its contribution to global public health initiatives, including:
- HIV/AIDS programs: Mylan played a key role in producing generic antiretroviral drugs.
- Biosimilars: Developing cost-effective biologics for conditions like cancer and autoimmune diseases.
High-Quality Standards
Mylan’s manufacturing facilities adhere to rigorous Good Manufacturing Practices (GMP) and global regulatory requirements. This ensures product safety and effectiveness for consumers worldwide.
Viatris: Mylan’s Next Chapter
In November 2020, Mylan merged with Pfizer's Upjohn division to form Viatris, a new global healthcare company. This merger expanded the combined entity’s reach and capabilities, enabling it to deliver:
- A broader portfolio of medicines.
- Enhanced global access to healthcare solutions.
- Improved efficiencies in supply chain and operations.
Popular Products by Mylan Pharmaceuticals
- EpiPen®: A life-saving auto-injector for severe allergic reactions (anaphylaxis).
- Antiretroviral Therapies: Generic options for managing HIV/AIDS.
- Biosimilars: Affordable alternatives for biologic drugs used in cancer and autoimmune conditions.
Corporate Social Responsibility
Mylan is deeply committed to sustainability and public health initiatives, such as:
- Collaborating with global health organizations to combat infectious diseases.
- Prioritizing environmental sustainability in manufacturing processes.
- Supporting access to medications in low- and middle-income countries.
Key Achievements
- Global Impact: Supplies one of the largest portfolios of generic drugs worldwide.
- Biosimilar Advancements: Among the first to market biosimilar drugs for complex diseases.
- Healthcare Leadership: Recognized for pioneering generic drugs and creating accessible healthcare solutions.
